UPDATE 1-U.S. FDA panel backs claim Lilly diabetes drug cuts cardiac death

June 28 (Reuters) - Eli Lilly & Co and Boehringer

Ingelheim should be allowed to claim that their diabetes drug

Jardiance cuts the risk of cardiovascular death, an advisory

panel to the U.S. Food and...

Read more